STOCKS NEWS EUROPE-Prostrakan up on bullish update

Shares in Prostakan (PSK.L) climb 3.3 percent after the Scottish speciality pharmaceutical company delivers "an exciting mix of better than anticipated revenues" for the first four months of 2009, according to Numis.

Prostrakan reports a 40 percent sales growth for the first four months of 2009 against the same period in 2008.

"Sales of the group's core products surprised positively, with major pan-European products up 50 percent and even the supposedly maturing AdCal D3 up 20 percent," says Numis in a note.

"With promises kept, everything is on track for ProStrakan to achieve breakeven towards the end of 2009," the broker adds.

For more double click on [ID:nRnsN2086S]

Reuters Messaging rm://david.brett.reuters.com@reuters.net